首页 | 本学科首页   官方微博 | 高级检索  
检索        


Docetaxel or pemetrexed with or without cetuximab in recurrent or progressive non-small-cell lung cancer after platinum-based therapy: a phase 3, open-label,randomised trial
Authors:Edward S Kim  Marcus Neubauer  Allen Cohn  Lee Schwartzberg  Lawrence Garbo  John Caton  Francisco Robert  Craig Reynolds  Terry Katz  Sreeni Chittoor  Lorinda Simms  Scott Saxman
Institution:1. Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA;2. Kansas City Cancer Center, Overland Park, KS, USA;3. US Oncology Research, Houston, TX, USA;4. Rocky Mountain Cancer Center, Denver, CO, USA;5. The West Clinic, Memphis, TN, USA;6. New York Oncology Hematology, Albany, NY, USA;7. Willamette Valley Cancer Institute and Research Center, Eugene, OR, USA;8. Department of Medicine, Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL, USA;9. Ocala Oncology Center, Ocala, FL, USA;10. ImClone Systems LLC, Branchburg, NJ, USA;11. Texas Oncology PA, Dallas, TX, USA;12. Eli Lilly Inc, Toronto, ON, Canada;13. Eli Lilly and Company, Indianapolis, IN, USA
Abstract:
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号